Cancer Products
-
A&G’s therapeutics division is pursuing development of anti-GP88 and other
monoclonal antibody drugs for cancer. On the diagnostics side, A&G is
developing tissue and serum test kits that will improve early detection, diagnosis,
and treatment of breast cancer based on GP88.